Education
About Us
Working with TipRanks
Follow Us
Peter Castleman Insider Profile
4 Followers
Peter Castleman, Director at Herbalife, holds 1.64M shares in Herbalife (Ticker: HLF), holds 10.39M shares in Caris Life Sciences, Inc. (Ticker: CAI), holds 164.74K shares in Neurometrix (Ticker: NURO). Most recently, Peter Castleman ― shares of Herbalife on ― for an estimated value of ―.
Peter Castleman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter Castleman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Peter Castleman
Peter Castleman's Trading History
Herbalife
―
Director
―
$15.51M
Caris Life Sciences, Inc.
Jun 23, 2025
Director
Uninformative Buy
―
$396.99M
Neurometrix
―
―
―
$754.51K
Aecom Technology
―
Ten Percent Owner
―
$0.00
RBC Bearings
―
Ten Percent Owner
―
$0.00
List of latest transactions for each holding click on a transaction to see Peter Castleman's performance on stock
You May Also Like
Peter Castleman insider profile FAQ
What is the percentage of profitable transactions made by Peter Castleman?
The percentage of profitable transactions made by Peter Castleman is ―.
What is the average return per transaction made by Peter Castleman?
The average return per transaction made by Peter Castleman is ―.
What stocks does Peter Castleman hold?
Peter Castleman holds: HLF, CAI, NURO, ACM, RBC stocks.
What was Peter Castleman’s latest transaction?
Peter Castleman latest transaction was an Uninformative Buy of ―.
What was Peter Castleman's most profitable transaction?
Peter Castleman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Peter Castleman's role in Herbalife?
Peter Castleman's role in Herbalife is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.